General Electric Company (NYSE:GE)

During Thursday’s Afternoon trade, Shares of General Electric Company (NYSE:GE), dropped -0.54% to $30.50. The firm opened its current trade at $30.41, and as of now, it is trading at $30.50. The total volume traded for the day is 157.23M shares, as compared to its average daily volume of 85.77M shares. The stock is floating in a range of $30.35 - $30.90. The stock holds the market capitalization of $308.38B.

GE [NYSE:GE] declared the appointment of four new Company officers. Effective December 1, GE will have 195 officers globally who lead large revenue-generating businesses or critical technology or functional roles.

Michael Chanatry, 55, was designated vice president of supply chain for Power Generation Products - GE Power. Chanatry joined GE in 1983 and has held leadership roles in GE Aerospace, GE Aviation and GE Appliances. Most recently at GE Appliances he served as general manager for supply chain, and preceding to that worked as the supply chain leader at Aviation Systems. Chanatry holds a bachelor’s degree in business administration from Niagara University, Niagara, NY.

Deirdre Latour, 42, was designated vice president and chief communications officer of GE. Latour joined GE in 2004 and has held a series of leadership roles in GE Corporate. She was named chief communications officer in April 2015. Formerly Latour was senior director of external communications at GE and held leadership positions at Edelman preceding to joining GE. Latour holds a bachelor’s degree in history from Holy Cross in Worcester, MA.

Yuvbir Singh, 42, was designated vice president of global locomotive organization - GE Transportation. Singh joined GE in 1995 and has held leadership positions at GE Power. While at GE Power, he served as senior executive of business operations for GE Water. Singh joined GE Transportation in October 2015 to lead global locomotive organization. He holds a bachelor’s degree in electronics engineering from University of Pune and attended school at Dr. D.Y. Patil College of Engineering, Pune, India.

Jim Waterbury, 58, was designated vice president, M&A counsel - GE, and general counsel - GE Capital. Waterbury joined GE in 1991 and has held leadership roles in GE Power, GE Oil & Gas, GE Capital and GE Corporate. Most recently, he served as senior executive counsel of mergers and acquisitions for GE Corporate. Waterbury holds a certificate in political science from the Institut d’Etudes Politiques, Paris, France and both a bachelor’s degree in government and languages and a J.D. from Georgetown University, Washington, D.C.

General Electric Company operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.

Sunedison Inc (NYSE:SUNE)

Shares of Sunedison Inc (NYSE:SUNE), gained 0.82% to $4.94, during its current trading session, on Thursday, despite the company declaring a new dividend recently.

SunEdison’s board of directors declared a quarterly dividend on its Series A Perpetual Convertible Preferred Stock in the prorated amount of $18.75 per share.

The dividend is payable on December 1 to shareholders of record as of November 15.

Before the market open on Tuesday, the renewable energy development company stated a loss of 91 cents per share on revenue of $476 million for the most recent quarter. Analysts had predictable SunEdison to report a loss of 69 cents a share on revenue of $437.45 million for the third quarter of 2015.

The stock plunged by 24% to hit a nearly two-and-a-half-year low following the report on Tuesday.

SunEdison, Inc. develops, manufactures, and sells silicon wafers to the semiconductor industry. The company operates through three segments: Solar Energy, TerraForm Power, and Semiconductor Materials. The Solar Energy segment provides solar energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the downstream solar market.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Finally, Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), dipped -4.31%, and is now trading at $75.46.

Bill Rietkerk, a New York dermatologist, thought it was a win-win situation.

Prescriptions he wrote were routinely filled by a pharmacy partner of drugmaker Valeant Pharmaceuticals International Inc. called Philidor Rx Services, which dispensed brand-name drugs he wanted his patients to get, even when they couldn’t win their insurers’ OK — or if they didn’t even have insurance. And he said the relationship was great for his staff, because Philidor took over some of the paperwork that bogs down the day-to-day operations of many doctor’s offices, according to Bloomberg

The convenience may have come at a steep cost to the health-care system by making it easier for doctors to get brand-name drugs into the hands of their patients instead of cheaper generics. Bloomberg Report

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.